E Fund Management Co., Ltd. Deciphera Pharmaceuticals, Inc. Transaction History

E Fund Management Co., Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.58 - $17.36 $140,050 - $179,033	10,313 New	10,313 $162,000
Q2 2023 Aug 11, 2023	SELL	$13.28 - $15.96 $11,407 - $13,709	-859 Reduced 6.46%	12,429 $175,000
Q1 2023 May 11, 2023	BUY	$14.26 - $22.1 $698 - $1,082	49 Added 0.37%	13,288 $205,000
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $9,622 - $12,337	-648 Reduced 4.67%	13,239 $217,000
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $50,337 - $82,255	-4,066 Reduced 22.65%	13,887 $257,000
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $29,489 - $45,253	-3,237 Reduced 15.28%	17,953 $236,000
Q1 2022 May 12, 2022	BUY	$6.87 - $11.11 $22,375 - $36,185	3,257 Added 18.16%	21,190 $196,000
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $113,297 - $546,330	14,714 Added 457.1%	17,933 $175,000
Q1 2021 May 12, 2021	BUY	$40.39 - $56.73 $130,015 - $182,613	3,219 New	3,219 $144,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.